While the immediate application is diagnosing MDS and leukemia risk, researchers believe the technique could eventually be used to detect a range of blood-related disorders earlier and less invasively.

A simple blood test procedure could screen for leukemia non-invasively, well before symptoms begin to express, revolutionizing the ability of the medical community to effectively target and treat the disease.

Once again, Israeli medical research and innovation lead the fight against cancer!

When Nathan Trylesinski was told that he couldn't become a combat soldier, he did everything in his power to make his dream come true true and give back to his country.

A team at Israel’s Hebrew University made one of the most important leukemia research breakthroughs in 40 years, putting a cure for the disease within reach for the first time ever.

MRI-focused ultrasound brain treatment from Israel’s Insightec is used at Haifa’s Rambam Medical Center to cure patients of tremor.

Israeli students developed a one-handed thoracic portal opener that shortens the procedure time of chest-tube insertion from minutes to less than 30 seconds, and another Israeli researcher has discovered that Gallium in liquid form can rapidly halt uncontrolled bleeding, without causing blood clots.

Tel Aviv University Professor Itzhak Fried has completed his study of how memory neurons behave in real time. These have important implications for understanding dementia such as Alzheimer’s, and an Israeli developed the world’s first search engine for information about hospitals.

An Israeli researcher from the Weizmann Institute of Science is behind a potential treatment for cancer with near-perfect results.

A cancer study hailed this week as potentially showing revolutionary results for the treatment of leukemia is based on research undertaken by Prof. Zelig Eshhar of Israel's Weizmann Institute of Science.

Israel’s DIR Technologies has invented a system that checks every package of medicine using thermal imaging, and joint Israeli-US research has discovered that the absence of protein RFX in many elderly people causes hearing loss.

Israel’s BiolineRx has reported positive results from Phase II trials of its BL-8040 treatment in relapsed or refractory acute myeloid leukemia and researchers at the Hebrew University of Jerusalem have uncovered a key gene responsible for ovary development.

A new Israeli program calms children with autism spectrum disorder (ASD), and researchers at IBM Israel developed an app that can detect attention deficit hyperactivity disorder (ADHD) symptoms.